ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
GenMark Diagnostics Inc

GenMark Diagnostics Inc (GNMK)

24.05
0.00
(0.00%)
Closed August 19 4:00PM
24.05
0.00
( 0.00% )
Pre Market: 8:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
24.05
Bid
23.92
Ask
24.39
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
24.05
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GNMK Latest News

Novelis Announces Launch of Initial Public Offering Roadshow

Novelis Announces Launch of Initial Public Offering Roadshow PR Newswire ATLANTA, May 28, 2024 ATLANTA, May 28, 2024 /PRNewswire/ -- Novelis Inc., a leading sustainable aluminum solutions...

2 growth stocks that benefit from Australia’s $8 billion animal obsession

http://www.fool.com.au/2015/11/16/2-growth-stocks-that-benefit-from-australias-8-billion-animal-obsession/?utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub

Novelis Inc. Commences Tender Offer and Consent Solicitation and Change of Control Offer for 7-1/4% Senior Notes Due 2015

ATLANTA, May 16 /PRNewswire-FirstCall/ -- Novelis Inc. announced today the commencement of a cash tender offer to purchase all of its outstanding $1.4 billion principal amount of 7-1/4% Senior...

Novelis Receives Court Approval for Acquisition by Hindalco

ATLANTA, May 14 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE:NVL) (TSX: NVL) announced today that it has received approval from the Ontario Superior Court of Justice for the arrangement whereby...

Novelis Shareholders Approve Acquisition by Hindalco

ATLANTA, May 10 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE:NVL) (TSX: NVL) announced today that at a special meeting of shareholders held today in Atlanta, Ga., its shareholders voted to...

Novelis Wins World Excellence Award From Ford

ATLANTA, May 2 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE:NVL) (TSX: NVL) has received a World Excellence Award from Ford Motor Company for its contribution to customer satisfaction. The...

The U.S. Conference of Mayors, Novelis and Keep America Beautiful, Inc. Launch Cans for Cash Recycling Challenge

Building a Sustainable Environment for Your Community WASHINGTON, April 26 /PRNewswire-FirstCall/ -- The U.S. Conference of Mayors, Novelis Inc., (NYSE, TSX: NVL) the global leader in aluminum...

Novelis Recycles 45 Percent of all Aluminum Cans Collected in North America

Recycling That Works: Locally and Globally CLEVELAND, April 4 /PRNewswire-FirstCall/ -- Novelis Inc. has once again demonstrated its recycling leadership in North America by recycling 24 billion...

Novelis Marks Start-Up of Automotive Center With Order for DaimlerChrysler

ATLANTA, March 26 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE:NVL) (TSX: NVL) today marked the start-up of a new laser-cutting center for aluminum automotive sheet at its rolling mill in...

Novelis Recycles Record Number of Aluminum Cans in 2006

Recycling 38 billion beverage cans avoids six million tonnes of greenhouse gas emissions and saves the energy equivalent of 19 million barrels of oil ATLANTA, March 19 /PRNewswire-FirstCall/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INMInMed Pharmaceuticals Inc
$ 0.52
(251.35%)
17.48M
TGLTreasure Global Inc
$ 1.59
(174.14%)
20.71M
TTNPTitan Pharmaceuticals Inc
$ 10.10
(101.20%)
2.2M
AUUDAuddia Inc
$ 2.03
(76.52%)
9.13M
PITAHeramba Electric PLC
$ 3.35
(59.52%)
11.44M
MYNAMynaric AG
$ 2.00
(-51.81%)
57.27k
DBGIDigital Brands Group Inc
$ 0.82
(-24.77%)
6.57k
GOVXGeoVax Labs Inc
$ 5.50
(-23.08%)
615.92k
CINGCingulate Inc
$ 10.10
(-21.09%)
229.78k
NCNANuCana PLC
$ 8.01
(-17.42%)
79.87k
TANHTantech Holdings Ltd
$ 0.1541
(22.30%)
28.48M
TGLTreasure Global Inc
$ 1.59
(174.14%)
20.71M
INMInMed Pharmaceuticals Inc
$ 0.52
(251.35%)
17.48M
STISolidion Technology Inc
$ 0.298
(-1.68%)
13.75M
PITAHeramba Electric PLC
$ 3.35
(59.52%)
11.44M

GNMK Discussion

View Posts
mick mick 3 years ago
https://www.otcmarkets.com/stock/GNMK
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
reading congrats GenMark Diagnostics, Inc. (GNMK)'
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.05 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
23.92 24.39 - - -
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 3 years ago


πŸ‘οΈ0
mick mick 3 years ago


πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
24.01 ? 0.02 (0.08%)
Volume: 1,243,229 @04/16/21 5:41:52 PM EDT
Bid Ask Day's Range
23.99 25.0 23.99 - 24.03
GNMK Detailed Quote
πŸ‘οΈ0
vinsterr vinsterr 3 years ago
My second buyout by Roche! ANDS in 2011 250% gain overnight and this one! Lucky me!

πŸ‘οΈ0
mick mick 3 years ago
GenMark Diagnostics (GNMK)
20.68 ? -0.98 (-4.52%)
Volume: 1,223,813 @02/19/21 7:53:11 PM EST
Bid Ask Day's Range
19.3 20.65 20.28 - 21.8
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
https://otcbb.swingtradebot.com/equities/GNMK
πŸ‘οΈ0
mick mick 4 years ago
https://pennystocks.news/otc/?symbol=GNMK
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
13.99 ? -0.06 (-0.43%)
Volume: 116,280 @12/07/20 11:13:27 AM EST
Bid Ask Day's Range
13.97 14.01 13.83 - 14.296
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
13.79 ? 0.23 (1.70%)
Volume: 408,566 @11/17/20 3:44:44 PM EST
Bid Ask Day's Range
13.79 13.8 13.43 - 13.85
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.68 ? 0.38 (3.36%)
Volume: 853,580 @10/23/20 7:35:16 PM EDT
Bid Ask Day's Range
11.21 12.25 10.97 - 11.585
GNMK Detailed Quote
πŸ‘οΈ0
eastunder eastunder 4 years ago
GNMK Stock: Why GenMark Diagnostics Is Soaring Today
GenMark just received emergency approval from the FDA for its coronavirus test panel

By Sarah Smith, InvestorPlace Web Content Producer Oct 9, 2020, 9:00 am EDT

https://investorplace.com/2020/10/gnmk-stock-why-genmark-diagnostics-is-soaring-today/

GenMark Diagnostics (NASDAQ:GNMK) is looking to leverage new interest β€” and new necessity β€” when it comes to the novel coronavirus. News of its innovative test kit, and emergency-use authorization, is sending GNMK stock higher Friday.

So what exactly is happening? Well, GenMark Diagnostics is a provider of molecular diagnostics. It wants to make testing for all sorts of diseases and bacteria easier, better and more reliant on powerful technology. In fact, the company started back in 1993 with a bold idea for an electronic sensor that could detect DNA.

Clearly, GenMark knows a thing or two about diagnostics. With that in mind, it set out to develop the best test kit for the novel coronavirus. Importantly, it wanted to create something that offered more insight. If a patient has respiratory symptoms but not the coronavirus, GenMark wants to figure out what is causing those symptoms.

That idea is exactly what has GNMK stock popping on Friday. The company took its bold plan, and developed the ePlex Respiratory Pathogen Panel 2 (RP2). Investors should note that not only does this panel test for the coronavirus, but it also provides results for more than 20 different viruses and bacteria. Now, you can know in just two hours whether you have the coronavirus or something less sinister, like the flu or a common cold.

That makes a lot of sense, and thankfully, the U.S. Food and Drug Administration agrees. The regulatory agency just granted the ePlex panel an EUA.

GNMK Stock Pops on New Coronavirus Test
Perhaps one of the best way for investors to understand the importance of the ePlex panel is to examine a real-life example. GenMark tells a story of a nurse, an employee at a hospital that has been testing the panel. When she developed a fever at work, she was immediately able to use the panel. Instead of the coronavirus, she had a common cold.

This matters for two reasons. First, it set a clear path for when she could return to work. Second, it provided more certainty. Simply testing negative for the coronavirus may not give peace of mind. But with the ePlex panel, you know exactly what is causing your symptoms.

As a second β€” or third β€” wave of the coronavirus continues to hit the world, and as flu season ramps up, this diagnostic panel will be more important than ever. Consider the wide variety of viruses and bacteria it tests for, and also its two-hour turnaround time. Like with the nurse, the ePlex panel could very well be what investors are waiting for. In other words, it could help bring about a return to normal.

Nothing is a sure thing in the coronavirus drug and vaccine race, but GNMK stock is worthy of staying on your radar.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Sarah Smith is a Web Content Producer for InvestorPlace.com.
πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
GNMK COVID NEWS AND THIN ASK ALL THE WAY TO OVER $30. ON WATCH ALL DAY LONG
πŸ‘οΈ0
whytestocks whytestocks 4 years ago
BREAKING NEWS: $GNMK Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments Canada NewsWire MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST)...

In case you are interested GNMK - Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.6 ? -0.12 (-1.02%)
Volume: 1,638,836 @09/04/20 6:48:00 PM EDT
Bid Ask Day's Range
10.5 11.6 10.6 - 11.793
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
15.23 ? -0.72 (-4.51%)
Volume: 940,835 @08/14/20 5:48:51 PM EDT
Bid Ask Day's Range
15.01 17.4 15.02 - 15.97
GNMK Detailed Quote
πŸ‘οΈ0
Gpheart2016 Gpheart2016 4 years ago
I must be missing something. Second qtr results: beat on earnings and revenue but stock is down 15%? Maybe a good chance to buy more.
πŸ‘οΈ0
mick mick 4 years ago
$GNMK GenMark Diagnostics (GNMK)
16.8 ? -1.13 (-6.30%)
Volume: 938,241 @07/24/20 7:00:07 PM EDT
Bid Ask Day's Range
16.75 17.39 16.41 - 17.83
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
$GNMK STRONG HANDS !!!!!
πŸ‘οΈ0
xray168 xray168 4 years ago
What a run from 4$!
πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $GNMK Video Chart 07-08-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
14.09 ? -0.61 (-4.15%)
Volume: 3,638,855 @06/26/20 7:59:56 PM EDT
Bid Ask Day's Range
13.0 14.18 13.92 - 14.99
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago


[-chart]www.stockscores.com/chart.asp?TickerSymbol=GNMK&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
9.14 ? -0.465 (-4.84%)
Volume: 1,415,808 @06/05/20 7:29:15 PM EDT
Bid Ask Day's Range
8.08 10.05 9.06 - 10.05
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
9.63 ? 0.06 (0.63%)
Volume: 2,775,866 @05/27/20 6:44:55 PM EDT
Bid Ask Day's Range
9.12 9.9 8.47 - 9.67
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
11.835 ? -1.005 (-7.83%)
Volume: 2,397,719 @05/08/20 3:12:05 PM EDT
Bid Ask Day's Range
11.83 11.84 11.52 - 12.3899
GNMK Detailed Quote
πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $GNMK Video Chart 05-07-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
mick mick 4 years ago
https://otcbb.swingtradebot.com/equities/GNMK
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics (GNMK)
7.61 ? 0.41 (5.69%)
Volume: 2,843,077 @04/16/20 2:34:58 PM EDT
Bid Ask Day's Range
7.6 7.62 7.0 - 7.62
GNMK Detailed Quote
πŸ‘οΈ0
mick mick 4 years ago


[-chart]www.stockscores.com/chart.asp?TickerSymbol=GNMK&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
πŸ‘οΈ0
mick mick 4 years ago
8 day-50 day-200 day-https://www.barchart.com/stocks/quotes/GNMK/technical-chart
πŸ‘οΈ0
mick mick 4 years ago
EARLY RISER PPS $GNMK
πŸ‘οΈ0
Homebrew Homebrew 4 years ago
So ? That's only meaningless daily short "volume". Merely MMs doing their jobs, to process intra-day orders for thinly traded stocks.

Short INTEREST are open short positions needing to be bought back at some point in the future.
πŸ‘οΈ0
mick mick 4 years ago
GNMK The short sale volume percent (not short interest) for stock ticker GNMK is 45% on Apr 08, 2020. The short sale volume is 2,560,620. The total volume is 5,664,938. The short sale volume percent is down -6% compare to Apr 07, 2020.
πŸ‘οΈ0
mick mick 4 years ago
GenMark Diagnostics, Inc (NASDAQ: GNMK) announced preliminary first-quarter results, expecting revenues of about $38.7 million, a 80% year-over-year increase.

The company noted that about 80% gross placements included interest in COVID-19 testing SARS-CoV-2 consumable revenues. Analysts, on average, estimate revenues of $24.8 million.

The company also raised its full-year revenue guidance from $100-$110 million to $112-$122 million, while the consensus calls for revenues of $108.58 million.

The stock climbed 29.56% to $5.83 in after-hours trading.

Zomedica Prices Offering of Common Stock, Warrants
πŸ‘οΈ0
mick mick 4 years ago
4 analysts offering 12-month price forecasts for Genmark Diagnostics Inc have a median target of 10.00,

with a high estimate of 11.00 and a low estimate of 8.00.

The median estimate represents a +119.30% increase from the last price of 4.56.


https://money.cnn.com/quote/forecast/forecast.html?symb=GNMK
πŸ‘οΈ0
finna_make_gains finna_make_gains 4 years ago
May options $5 going to be in the money
πŸ‘οΈ0
mick mick 4 years ago
looks exciting at this level. 'GenMark Diagnostics, Inc. (GNMK)'
πŸ‘οΈ0
xray168 xray168 4 years ago
buying here at low 4s look safe to me
πŸ‘οΈ0
mick mick 4 years ago
Investors in GenMark Diagnostics, Inc. GNMK need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2020 $7.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for GenMark shares, but what is the fundamental picture for the company? Currently, GenMark is a Zacks Rank #3 (Hold) in the Medical - Instruments industry that ranks in the Top 17% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has narrowed our Zacks Consensus Estimate for the current quarter from a loss of 17 cents per share to a loss of 16 cents in that period.

Given the way analysts feel about GenMark right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?
πŸ‘οΈ0
Pedro2004 Pedro2004 4 years ago
LOL...the company is going to dilute this POS back under $4 dollars.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock